Advantages and Disadvantages of MRM/PRM Techniques

By Barbara Jackson · Published: October 8, 2024

After a discovery experiment, a laboratory often holds a short protein list that still needs fragment-level confirmation in a complex digest. Parallel reaction monitoring (PRM) isolates scheduled precursor ions and records a high-resolution fragment-ion spectrum for each of those precursors. The practical advantages are post-acquisition fragment choice and better discrimination of some co-isolated background. The matching costs are a closed precursor list, a duty cycle set by MS2 fill and scan time, and isolation windows that can still admit interference. Multiple reaction monitoring (MRM) on a triple quadrupole is a different bargain.

 

Why PRM Follows a Closed Precursor List

PRM is a targeted method. Precursors must be named before acquisition, usually from a discovery matrix, a spectral library, or a pathway panel. The scientific question has already shifted from which proteins can be observed to whether a defined peptide set can be measured with enough fragment evidence to support a group comparison. Sensitivity and scan coverage are therefore judged on that scheduled list, because PRM records the named precursors rather than an untargeted proteome.

 

Peterson et al. 2012 described PRM on a quadrupole-Orbitrap as precursor isolation followed by parallel detection of all product ions at high resolution and high mass accuracy. That design is why method development can be lighter than MRM transition picking, and why some unit-resolution interferences can be separated after the run. Researchers can refer to PRM LC-MS Targeted Proteomics for how a scheduled LC-MS assay is built from that acquisition model. Orbitrap fill time and transient length also set how many precursors fit in one chromatographic peak. For a principal investigator, the decision is whether that fragment-rich, multiplex-limited assay matches the remaining samples and the sentence required for the paper.

 

How PRM Turns a Scheduled Precursor into a Peak Area

Proteins are digested, most often with trypsin, and proteotypic peptides are treated as surrogates. In a quadrupole-Orbitrap or quadrupole-time-of-flight instrument, quadrupole 1 (Q1) isolates a precursor m/z window. The precursor is fragmented in a collision cell. The high-resolution analyzer then records product ions from that precursor in one MS2 event. Quantitative traces are extracted from selected fragment chromatograms, usually as peak area. Fragments that show interference can be dropped after inspection, because the spectrum was stored.

 

Q1 isolation is still a window, commonly on the order of 0.7 to 2 Th in published PRM methods. Co-isolated ions can fragment together with the target. High-resolution detection can separate many of those fragments by accurate mass. When two peptides share the isolation window and yield overlapping fragments, unique precursor assignment still depends on chromatography and fragment review. Automatic gain control, maximum fill time, and resolution setting decide how many ions are accumulated and how long each MS2 costs. Those parameters, together with the scheduled retention-time window, set the usable panel size.

 

A PRM signal is the extracted peak area of selected fragments from a scheduled precursor.

 

PRM workflow from precursor selection and CID to recording all product ions and extracting a chromatographic peak area

Figure 1. PRM isolates a scheduled precursor, records its product ions at high resolution, and quantifies from extracted fragment peak areas.

 

Advantages That Hold After Assay Conditions Are Set

PRM advantages are conditional. They appear when the precursor list is closed, chromatography can hold peptides in their schedule windows, and fragments will be reviewed in the study matrix.

 

1. Full fragment evidence without preselecting every transition

MRM requires chosen precursor-to-product pairs before the cohort is queued. PRM stores the fragment spectrum of each scheduled precursor, so quantitative and qualifier ions can be selected or replaced during data review (Peterson et al. 2012). That flexibility shortens early method development and helps when a library spectrum is incomplete. Extracted traces still need interference review in the real digest.

 

2. High-resolution discrimination in complex matrices

Accurate-mass fragments can separate product ions that would share a unit-resolution Q3 window on a triple quadrupole. Shi et al. 2016 placed PRM as a high-resolution alternative when sample complexity produces co-eluting background. The gain is for the extracted fragments that are resolved. A noisy precursor isolation still lowers the useful ion current of the target. Plasma and other high-dynamic-range matrices may still need enrichment or more input.

 

3. Sequence-defined measurement without an antibody

PRM measures a peptide sequence and its fragments. A new target can be added if a precursor can be scheduled and ionized. Antibody availability does not gate the assay. Specificity problems move to shared peptides, missed cleavage, variable modifications, and isolation-window interference. Modified peptides, including phosphorylation, often benefit from seeing the full fragment set when site-discriminating ions must be checked.

 

4. Relative comparison, with amount usually supported by a matched standard

Same-peptide peak areas can support a fold-change comparison when digestion, loading, and chromatography stay comparable. Peptide amount or concentration is usually reported with a matched stable isotope-labeled internal standard (SIS). The heavy peptide supports fragment co-elution checks and ratio calculation for steps after the spike. Intact-protein amount is reported when digestion efficiency, protein recovery, and surrogate-peptide representativeness are part of that design, often with a full-length labeled protein or a matched protein standard.

 

Planning Costs That Shape the PRM Run

1. A scheduled precursor list records named proteins

Only precursors that were placed on the inclusion list are fragmented in PRM. Proteins outside that list stay unmeasured in the PRM file. Data-dependent acquisition (DDA) or data-independent acquisition (DIA) remains the route when the protein inventory is still open. Recording all fragments of a precursor is fragment coverage of that peptide, not proteome coverage.

 

2. Cycle time limits the panel

Each MS2 event consumes fill time and analyzer time. Adding precursors shortens points across the chromatographic peak or forces extra injections. Large, mature panels that must run many times on a triple quadrupole can still favor MRM after transitions are clean. PRM is often the better next experiment for a small or medium set in a difficult matrix, where fragment confirmation is the scarce resource.

 

3. Isolation interference and fill-time trade-offs still exist

High resolution still operates behind a Q1 window. Automatic gain control can fill with matrix ions and leave few target ions for the transient. Narrower isolation, longer fill, or fewer concurrent precursors can restore fragment quality and will reduce multiplex capacity. Those parameters belong in the method record with the peak-area table.

 

4. Data review is heavier than a two-transition chromatogram

PRM files contain full MS2 traces for every scheduled precursor. Extracting, picking fragments, and documenting interference takes more review time than integrating a small MRM transition list. Software such as Skyline is a common environment for that work. Matrix-matched fragment QC still belongs with the peak-area table.

 

When PRM Fits as the Next Assay

The useful test is whether the precursor list is closed, whether fragment confirmation is needed in the study matrix, and whether the panel fits one PRM duty cycle.

 

Study condition

PRM is often useful

Planning note

Target definition

Precursors can be named and scheduled

Keep DDA or DIA while protein names are still being opened

Interference risk

Complex digest where unit-resolution transitions are untrusted

A clean matrix with already validated MRM transitions can stay on the QQQ panel

Panel size

Small to medium set that fits the MS2 cycle

Extra injections or an MRM translation are used when peak sampling collapses

Method development time

Fragments still need to be chosen or swapped

A locked QQQ panel is the usual route when the same transitions will be repeated at large scale

Quantification

Same-peptide relative comparison, or peptide amount with a matched SIS

Intact-protein amount adds digestion efficiency, protein recovery, and a protein-level standard

Adjacent option

High-resolution targeted confirmation after discovery

Open-proteome discovery stays on DDA or DIA until the inclusion list can be frozen

Decision checkpoints for PRM: closed precursor list, need for full MS2, and a small to medium panel

Figure 2. PRM advantages apply when precursors are closed, fragment confirmation is required, and the panel still fits the MS2 cycle time.

 

In MtoZ Biolabs targeted proteomics offerings, PRM and MRM/SRM are separate acquisition choices. PRM is typically run on a high-resolution quadrupole-Orbitrap or Q-TOF class instrument. MRM/SRM is typically run on a triple quadrupole. Sensitivity should be compared in the study matrix. Instrument class alone does not rank the two methods. If names do not yet exist, discovery acquisition should stay in place.

 

If the remaining task is a large, scheduled QQQ panel, researchers can refer to Advantages and Disadvantages of Multiple Reaction Monitoring for a more detailed trade-off framework.

 

Laboratories with a defined precursor list can also review the MtoZ Biolabs Parallel Reaction Monitoring (PRM) Service for project-specific feasibility and analysis planning.

 

Frequently Asked Questions

1. What does a PRM method measure in the sample?

PRM measures scheduled precursors only. All product ions of those precursors can be recorded in the MS2 event. Proteins that were never placed on the inclusion list are not quantified, even if they are abundant.

 

2. How is PRM sensitivity compared with MRM in a study matrix?

Ranking depends on matrix and panel size. High-resolution fragments can improve selectivity in complex samples, which may lower the usable limit for some peptides (Peterson et al. 2012; Shi et al. 2016). Triple-quadrupole MRM can still deliver more points across a peak for a large, scheduled panel. Compare the two methods on the peptides and matrix that matter for the study.

 

3. When are isotope-labeled standards used in a PRM assay?

Relative comparison of the same peptide can proceed without an SIS if digestion and chromatography remain comparable. Peptide amount or concentration is usually reported with a matched heavy peptide added at a point that matches that claim. Intact-protein amount uses digestion efficiency, protein recovery, and often a full-length labeled protein or a matched protein standard.

 

4. How does PRM sit beside discovery DDA or DIA?

PRM records proteins on the inclusion list. Keep DDA or DIA while new names are still required. Move to PRM when the precursor list can be frozen and fragment-level confirmation is the next task.

 

5. How many peptides can one PRM method include?

The number is set by chromatographic peak width, resolution, fill time, and how many MS2 events must sample each peak. A small candidate set after discovery often fits one method. A large panel may need extra injections or a later MRM translation once fragments are chosen.

 

MtoZ Biolabs can provide parallel reaction monitoring and targeted proteomics analysis for predefined protein or peptide panels, including relative quantification and isotope-assisted absolute quantification when the study design requires matched internal standards.

 

If further evaluation of precursor lists, matrix interference, panel size, or PRM versus MRM routing is needed, project details can be submitted for a feasibility review.

Support Documents

Protein Quantification for Deeper Discovery

Gain a clearer understanding of protein quantification approaches and their applications in studying protein abundance changes by downloading our detailed brochure.

Submit the form below to download the
This checkbox is required
* I agree to receive other communications from MtoZ Biolabs, which may contain technical or marketing information. You can unsubscribe from thlese communications at any time.
SUBMIT
 

How to Order

How to Order
Request a Quote

Request a Project Quote

Please complete the required fields below. We will review your information and respond with a tailored recommendation.

Project inquiry

Fields marked with * are required for quote review.

Secure inquiry · No obligation
Required Information

Your information will be used only to respond to your inquiry.

Submit Inquiry